RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCT

NCT05858814 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

BIOLOGICAL: RC1012 injection (allo-DNT cells)

Sponsor

Guangdong Ruishun Biotech Co., Ltd

Collaborators

[object Object]